Pexidartinib Long-Term Hepatic Safety Profile in Patients with Tenosynovial Giant Cell Tumors - Lewis, James H. (MedStar Georgetown University Hospital) ; Gelderblom, Hans J (Leiden University Medical Center) ; van de Sande, Michiel (Leiden University Medical Center (Països Baixos)) ; Stacchiotti, Silvia (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ; Healey, John H. (Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College (Nova York, Estats Units d'Amèrica)) ; Tap, William D. (Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College (Nova York, Estats Units d'Amèrica)) ; Wagner, Andrew J. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; López Pousa, Antonio (Institut d'Investigació Biomèdica Sant Pau) ; Druta, Mihaela (Moffitt Cancer Center (Tampa, Florida)) ; Lin, ChiaChi Chi Josh (National Taiwan University Hospital (Taipei, Taiwan)) ; Baba, Hideo Andreas (University Hospital Essen (Alemanya)) ; Choi, Youngsook (Daiichi Sankyo. Inc (Nova Jersey, Estats Units)) ; Wang, Qiang (Daiichi Sankyo. Inc (Estats Units)) ; Shuster, Dale E. (Daiichi Sankyo. Inc (Estats Units))) ; Bauer, Sebastian (University of Duisburg-Essen (Alemanya))
 
Comments (0) | Reviews (0)
Be the first to review this document.

Add review

Rate this article:
Give a title to your review:
Write your review:
Note: you have not defined your nickname.
N/D will be displayed as the author of this comment.